Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protective Effects of Antioxidants, Verapamil, and Losartan in ESWL
NCT01675362Phase 4Completed
- Sponsor
- Mansoura University
- Start
- Aug 2012
- Primary completion
- Aug 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of verapamil, losartan, selenium, vitamin a, ascorbic acid in nephrolithiasis, sponsored by Mansoura University. Started Aug 2012; status: completed.
02
Drugs
verapamillosartanseleniumvitamin aascorbic acid
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT01675362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01675362.